
Pharma Companies Are Taking Away Risk Through Spinoffs: Here's Why
This Week in Business
00:00
The Future of the IPO Market
We hadn't seen something like this in more than a year since Rivian back in late 2021. I hesitate to make broader predictions that this is going to revitalize the IPO market. We are living in an era in which we're still living through economic uncertainty and that feeds through not only from the public markets to the private markets. The market of course doesn't value something that's stable and that's what they're getting in this consumer health IPO.
Transcript
Play full episode